典型文献
The critical role of therapeutic plasma exchange in ABO-incompatible liver transplantation
文献摘要:
Background:The shortage of donor liver restricts liver transplantation(LT).Nowadays,donor liver with ABO blood group incompatibility between donor and recipient has become an option to expand the source of donor liver.Although it is now possible to perform ABO-incompatible(ABO-I)LT,antibody-mediated rejection(AMR)has been recognized as the primary cause of desperate outcomes after ABO-I LT.Anti-A/B antibody is the trigger of immune response to ABO-I LT graft injury.Therapeutic plasma ex-change(TPE)can quickly reduce the titer of plasma antibodies and effectively inhibit humoral immunity.Data sources:We searched PubMed and CNKI databases using search terms"therapeutic plasma ex-change","ABO-incompatible liver transplantation","ABO-I LT","liver transplantation","LT","antibody-mediated rejection",and"AMR".Additional publications were identified by a manual search of references from key articles.The relevant publications published before September 30,2020 were included in this review.Results:Different centers have made different attempts on whether to use TPE,when to use TPE and how often to use TPE.However,the control standard of lectin revision level is always controversial,the target titer varies significantly from center to center,and the standard target titer has not yet been estab-lished.TPE has several schemes to reduce antibody titers,but there is a lack of clinical trials that provide standardized procedures.Conclusions:TPE is essential for ABO-I LT.Hence,further research and clinical trials should be conducted to determine the best regimen for TPE to remove ABO antibodies and prevent AMR.
文献关键词:
中图分类号:
作者姓名:
Cheng-Zuo Han;Qiang Wei;Meng-Fan Yang;Li Zhuang;Xiao Xu
作者机构:
Department of Hepatobiliary and Pancreatic Surgery,The Center for Integrated Oncology and Precision Medicine,Affiliated Hangzhou First People's Hospital,Zhejiang University School of Medicine,Hangzhou 310006,China;Institute of Organ Transplantation,Zhejiang University,Hangzhou 310003,China;National Center for Healthcare Quality Management in Liver Transplant,Hangzhou 310003,China;Department of Hepatobiliary and Pancreatic Surgery,Shulan(Hangzhou)Hospital,Hangzhou 310022,China
文献出处:
引用格式:
[1]Cheng-Zuo Han;Qiang Wei;Meng-Fan Yang;Li Zhuang;Xiao Xu-.The critical role of therapeutic plasma exchange in ABO-incompatible liver transplantation)[J].国际肝胆胰疾病杂志(英文版),2022(06):538-542
A类:
desperate
B类:
critical,role,therapeutic,plasma,exchange,ABO,incompatible,liver,transplantation,Background,shortage,donor,restricts,LT,Nowadays,blood,group,incompatibility,between,recipient,has,become,option,expand,Although,now,possible,perform,antibody,mediated,rejection,AMR,been,recognized,primary,cause,outcomes,after,Anti,trigger,immune,response,graft,injury,Therapeutic,TPE,quickly,reduce,antibodies,effectively,inhibit,humoral,immunity,Data,sources,We,searched,databases,using,terms,Additional,publications,were,identified,by,manual,references,from,key,articles,relevant,published,before,September,included,this,review,Results,Different,centers,have,made,different,attempts,whether,when,how,often,However,control,lectin,revision,level,always,controversial,target,varies,significantly,not,yet,estab,several,schemes,titers,but,there,lack,clinical,trials,that,provide,standardized,procedures,Conclusions,essential,Hence,further,research,should,conducted,determine,best,regimen,remove,prevent
AB值:
0.538072
相似文献
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。